The global ENT devices market should reach $14.1 billion by 2026 from $11.3 billion in 2021 at a compound annual growth rate (CAGR) of 4.6% for the forecast period of 2021 to 2026.
The hearing aid devices segment of the global ENT devices market is expected to grow from $5.8 billion in 2021 to $7.2 billion in 2026 at a CAGR of 4.5% for the forecast period of 2021 to 2026.
The surgical devices segment of the global ENT devices market is expected to grow from $1.8 billion in 2021 to $2.3 billion in 2026 at a CAGR of 4.5% for the forecast period of 2021 to 2026.
Report Scope
This research report presents an in-depth analysis of the ENT device market by product type and region. The report discusses the key inhibitors to the growth of the market for ENT devices. The report discusses the role of participants in the supply chain from manufacturers to researchers.
The report analyzes key companies operating in the global ENT devices market.
In this report, the ENT device market is segmented by product type and region. Based on product type, the market is segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, and speech aid devices. The market by region is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
However, this report does not cover imaging tests in the ENT field, ENT microscopes, Image guided-surgery systems, ENT workstations, cabinets, ENT exam tables, ENT operation tables, stretchers, beds, chairs, lights, and accessories used in ENT treatment.
The Report Includes
- An overview of the global ENT devices market
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the current and future market potential and quantification of ENT devices market based on region, and product
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
- Description of different types of ENT devices such as diagnostic devices, nasal splints, surgical devices, hearing aids and hearing implants and their current and historical market revenues
- Comprehensive company profiles of the leading players of the industry
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Methodology
- Information Source
- Geographic Breakdown
- Analyst's Credentials
- Related Reports
Chapter 2 Summary and Highlights
- Introduction
Chapter 3 Market Definitions and Disease Background
- Overview
- Definitions
- Disease Background
- Otology
- Rhinology
- Laryngology
Chapter 4 Market Trends
- Market Drivers
- Aging Population
- Growing Prevalence and Incidence of ENT Disorders
- Chronic Diseases
- Increasing Healthcare Expenditures
- Penetration of Medical Devices in Emerging Markets
- Market Restraints
Chapter 5 Market Breakdown by Product
- Introduction
- Diagnostic Devices
- Hearing Aid Devices
- Hearing Implants
- Speech Aid Devices
- Surgical Devices
Chapter 6 COVID-19 Impact
- Introduction
- Key Factors Underlying the Impact of COVID-19 on the Medical Device Industry
- Decline/Delay in Elective Procedures
- Supply Chain Disruptions
- Strong Impact on China
- Impact of COVID-19 on Medical Device Product Segments
- COVID-19 Impact on ENT Devices Market
Chapter 7 Market Breakdown by Region
- Market Overview and Discussion
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 8 Competitive Landscape
- Industry Scenario
- Company Shares
Chapter 9 Company Profiles
- Atos Medical
- B. Braun Melsungen Ag
- Cochlear Corp.
- Demant A/S
- Fujifilm Holdings Corp.
- Gn-Resound
- Hill-Rom Holdings Inc.
- Johnson & Johnson
- Medtronic
- Olympus Corp.
- Stryker Corp.
- Smith & Nephew
List of Tables
Summary Table: Global Market for ENT Devices, by Product Type, Through 2026
Table 1: Global Population, Aged 60 and Older, 2000-2050
Table 2: Global ENT Devices Market, by Product Type, Through 2026
Table 3: Global Market for ENT Diagnostic Devices, by Region, Through 2026
Table 4: Global Market for ENT Hearing Aid Devices, by Region, Through 2026
Table 5: Global Market for ENT Hearing Implants, by Region, Through 2026
Table 6: Global Market for ENT Speech Aid Devices, by Region, Through 2026
Table 7: Global Market for ENT Surgical Devices, by Region, Through 2026
Table 8: Global Market for ENT Devices, by Region, Through 2026
Table 9: North American Market for ENT Devices, by Country, Through 2026
Table 10: European Market for ENT Devices, by Country, Through 2026
Table 11: Asia-Pacific Market for ENT Devices, by Country, Through 2026
Table 12: RoW Market for ENT Devices, Through 2026
List of Figures
Summary Figure: Global Market Share of ENT Devices, by Product Type, 2020
Figure 1: Global Market Shares of ENT Devices, by Product Type, 2020
Figure 2: Global Market Shares of ENT Diagnostic Devices, by Region, 2020
Figure 3: Global Market Shares of ENT Hearing Aid Devices, by Region, 2020
Figure 4: Global Market Shares of ENT Hearing Implants, by Region, 2020
Figure 5: Global Market Shares of ENT Speech Aid Devices, by Region, 2020
Figure 6: Global Market Shares of ENT Surgical Devices, by Region, 2020
Figure 7: Global Market Shares of ENT Devices, by Region, 2020
Figure 8: Global Company Shares of ENT Diagnostic Devices, 2020
Figure 9: Global Company Shares of ENT Hearing Aids, 2020
Figure 10: Global Company Shares of ENT Hearing Implants, 2020
Figure 11: Global Company Shares of ENT Speech Aids, 2020
Figure 12: Global Company Shares of ENT Surgical Devices, 2020
Samples
LOADING...
Executive Summary
Growth in this market is being fueled by a worldwide increase in aging populations and associated ENT disorders. There are growing cases of ear, nose and throat disorders such as sinusitis, otitis media, tonsillitis, eustachian tube dysfunction, and nasal airway obstruction. Technological innovation is an additional important catalyst driving the adaptation and increase in the use of ENT devices.
In 2020, the ENT devices market was significantly impacted by the COVID-19 pandemic, which led to the shutdown of ENT clinics and the postponement of elective ENT procedures. The transition towards normalcy in the second half of 2021 and the resumption of elective procedures is driving the sales of ENT devices.
Companies Mentioned
- Atos Medical
- B. Braun Melsungen Ag
- Cochlear Corp.
- Demant A/S
- Fujifilm Holdings Corp.
- Gn-Resound
- Hill-Rom Holdings Inc.
- Johnson & Johnson
- Medtronic
- Olympus Corp.
- Smith & Nephew
- Stryker Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 59 |
| Published | November 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 11.3 Billion |
| Forecasted Market Value ( USD | $ 14.1 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
